Pregled bibliografske jedinice broj: 1181355
Spermatogonial Stem Cell Cryopreservation for Fertility Preservation
Spermatogonial Stem Cell Cryopreservation for Fertility Preservation // Stem Cells in Reproductive Tissues and Organs. Stem Cell Biology and Regenerative Medicine / Virant-Klun, Irma (ur.)., 2022. str. 155-177 doi:10.1007/978-3-030-90111-0_7
CROSBI ID: 1181355 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Spermatogonial Stem Cell Cryopreservation for
Fertility Preservation
Autori
Vilaj, Marija ; Golubić-Ćepulić, Branka ; Ježek, Davor
Vrsta, podvrsta i kategorija rada
Poglavlja u knjigama, pregledni
Knjiga
Stem Cells in Reproductive Tissues and Organs. Stem Cell Biology and Regenerative Medicine
Urednik/ci
Virant-Klun, Irma
Izdavač
Humana Press
Godina
2022
Raspon stranica
155-177
ISBN
978-3-030-90110-3
ISSN
2196-8985
Ključne riječi
Cancer ; Cryopreservation ; Fertility restoration ; Spermatogonia ; Spermatogonial stem cells ; Testicular tissue
Sažetak
Introduction: Recent advances in cancer treatment have led to a higher survival rate in children and young adults. However, oncological therapies are related to impaired fertility due to their direct toxic effect on gonadal function, causing the depletion of germ cell number, or they act indirectly by damaging the somatic testicular cells and spermatogonial stem cells (SSCs), which consequently results in later fertility disruption. Therefore, strategies for fertility preservation and subsequent restoration have become an important focus of researchers around the world. Methods: We summarize new knowledge on freezing spermatogonia stem cells to maintain fertility in humans. Results: Cryopreservation of spermatozoa is the most established method of fertility preservation before gonadotoxic treatments in male adolescents who have undergone puberty and it is nowadays a clinical routine. Meanwhile, fertility preservation and restoration in prepubertal boys for whom spermatogenesis has not yet started is challenging because they are unable to produce sperm. To date, all known strategies for this purpose are experimental and far from clinical application. The only currently available option of fertility preservation in this group of cancer patients is the cryopreservation of testicular tissue containing SSCs that can be later used for autologous transplantation in order to restore fertility. Conclusions: Despite the achievements in this field, cryopreserved human testicular tissue containing SSCs has not yet resulted in sperm production and it is, therefore, necessary to improve and standardize methods for testicular tissue and testicular cell cryopreservation, SSCs isolation, their in vitro culture, and propagation. Furthermore, refinement of sorting methods is also required to achieve the efficient enrichment of human spermatogonia and avoid the coincidental introduction of neoplastic cells.
Izvorni jezik
Engleski
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb